FIDELITY FUNDS减持昭衍新药(06127)44.57万股 每股作价约24.39港元

Core Viewpoint - Fidelity Funds reduced its stake in Zhaoyan New Drug (06127) by 445,700 shares at a price of HKD 24.3867 per share, totaling approximately HKD 10.8692 million, resulting in a new holding of 7.1303 million shares, representing 5.99% of the company [1] Summary by Category - Share Reduction - Fidelity Funds decreased its holdings by 445,700 shares [1] - The transaction price was HKD 24.3867 per share [1] - Total amount from the reduction was approximately HKD 10.8692 million [1] - Current Holdings - After the reduction, Fidelity Funds holds 7.1303 million shares [1] - The new holding percentage is 5.99% [1]